Ovary Transitional Cell Carcinoma, also known as malignant ovarian transitional cell neoplasm, is related to serous cystadenocarcinoma and hydronephrosis. An important gene associated with Ovary Transitional Cell Carcinoma is HNF1B (HNF1 Homeobox B), and among its related pathways/superpathways are Integrated breast cancer pathway and DNA IR-double strand breaks and cellular response via ATM. The drugs Cisplatin and Paclitaxel have been mentioned in the context of this disorder. Affiliated tissues include ovary and endothelial, and related phenotypes are Synthetic lethal with cisplatin and Decreased viability with cisplatin